- Home
- U vs IBRX Comparison
U vs IBRX Comparison
Compare U & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | U | IBRX |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 7.2B |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | U | IBRX |
|---|---|---|
| Price | $27.24 | $7.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 7 |
| Target Price | ★ $36.61 | $12.57 |
| AVG Volume (30 Days) | 9.1M | ★ 11.7M |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 42.86 | 38.71 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,849,648,000.00 | $113,288,000.00 |
| Revenue This Year | $15.81 | $88.59 |
| Revenue Next Year | $12.93 | $131.15 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 2.01 | ★ 668.31 |
| 52 Week Low | $16.78 | $1.95 |
| 52 Week High | $52.15 | $12.43 |
Technical Indicators
Market Signals| Indicator | U | IBRX |
|---|---|---|
| Relative Strength Index (RSI) | 48.17 | 56.95 |
| Support Level | $24.45 | $7.77 |
| Resistance Level | $29.96 | $8.54 |
| Average True Range (ATR) | 1.53 | 0.44 |
| MACD | -0.24 | 0.07 |
| Stochastic Oscillator | 28.30 | 86.72 |
Price Performance
Historical ComparisonAbout U Unity Software Inc.
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run, and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC, and other Americas, and key revenue is derived from the EMEA region. Its products are used in the gaming industry, retail, automotive, architecture, engineering, and construction.
About IBRX ImmunityBio Inc.
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.